MUMBAI, India--(BUSINESS WIRE)--Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE:524715) announced that USFDA has granted approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Flomax ®, tamsulosin capsules.
